Oramed Pharmaceuticals Inc. (NASDAQ: ORMP, TASE: ORMP) issued a letter to shareholders on June 25, 2026, outlining key financial and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Index Changes